These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 14982149)

  • 1. Structural genomics and the metabolome: combining computational and NMR methods to identify target ligands.
    Parsons L; Orban J
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):62-8. PubMed ID: 14982149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR screening in drug discovery.
    Moore JM
    Curr Opin Biotechnol; 1999 Feb; 10(1):54-8. PubMed ID: 10047510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
    Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational modeling of biologically active molecules using NMR spectra.
    Beger RD
    Drug Discov Today; 2006 May; 11(9-10):429-35. PubMed ID: 16635805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular modeling of hydration in drug design.
    Mancera RL
    Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural biology and drug discovery.
    Scapin G
    Curr Pharm Des; 2006; 12(17):2087-97. PubMed ID: 16796557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From drug target to leads--sketching a physicochemical pathway for lead molecule design in silico.
    Shaikh SA; Jain T; Sandhu G; Latha N; Jayaram B
    Curr Pharm Des; 2007; 13(34):3454-70. PubMed ID: 18220783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target selection for structural genomics.
    Brenner SE
    Nat Struct Biol; 2000 Nov; 7 Suppl():967-9. PubMed ID: 11104002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development.
    Rajamani R; Good AC
    Curr Opin Drug Discov Devel; 2007 May; 10(3):308-15. PubMed ID: 17554857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular descriptors and methods for ligand based virtual high throughput screening in drug discovery.
    Pozzan A
    Curr Pharm Des; 2006; 12(17):2099-110. PubMed ID: 16796558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR in drug discovery.
    Pellecchia M; Sem DS; Wüthrich K
    Nat Rev Drug Discov; 2002 Mar; 1(3):211-9. PubMed ID: 12120505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional genomics and NMR spectroscopy.
    Powers R
    Comb Chem High Throughput Screen; 2007 Sep; 10(8):676-97. PubMed ID: 18045080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of protein-ligand interaction fingerprints in docking.
    Brewerton SC
    Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ID NMR Methods in ligand-receptor interactions.
    Zartler ER; Yan J; Mo H; Kline AD; Shapiro MJ
    Curr Top Med Chem; 2003; 3(1):25-37. PubMed ID: 12577989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and mapping of small-molecule binding sites in proteins: computational tools for structure-based drug design.
    Sotriffer C; Klebe G
    Farmaco; 2002 Mar; 57(3):243-51. PubMed ID: 11989803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of NMR to structure-based drug design in structural genomics.
    Powers R
    J Struct Funct Genomics; 2002; 2(2):113-23. PubMed ID: 12836668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial preface.
    Nilsson L; Åqvist J
    Biochim Biophys Acta; 2015 May; 1850(5):859-860. PubMed ID: 25615536
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of molecular dynamics on drug design: applications for the characterization of ligand-macromolecule complexes.
    Mortier J; Rakers C; Bermudez M; Murgueitio MS; Riniker S; Wolber G
    Drug Discov Today; 2015 Jun; 20(6):686-702. PubMed ID: 25615716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.